Not logged in Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer Shore, Neal D.; Luz, Murilo de Almeida; De Giorgi, Ugo; Gleave, Martin; Gotto, Geoffrey T.; Pieczonka, Christopher M.; Haas, Gabriel P.; Kim, Choung-Soo; Ramirez-Backhaus, Miguel; Rannikko, Antti; Kalac, Matko; Sridharan, Swetha; Rosales, Matt; Tang, Yiyun; Tutrone Jr, Ronald F.; Venugopal, Balaji; Villers, Arnauld; Woo, Henry H.; Wang, Fong; Freedland, Stephen J. Share Save
Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical Trial De La Cerda, Jose; Belkoff, Laurence; Courtney, Kevin D.; Diamond, Elan; D'Olimpio, James; Dunshee, Curtis; Gervasi, Lawrence; Goodman, Michael; Mittal, Kriti; Morris, David; Sieber, Paul; Tutrone, Ronald; Ryan, Michael; Zhong, Yi; Ufer, Mike; Shore, Neal Share Save
Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial Hansen, Aaron R.; Probst, Stephan; Beauregard, Jean-Mathieu; Viglianti, Benjamin L.; Michalski, Jeff M.; Tagawa, Scott T.; Sartor, Oliver; Tutrone, Ronald F.; Oz, Orhan K.; Courtney, Kevin D.; Delpassand, Ebrahim S.; Nordquist, Luke T.; Osman, Medhat M.; Chi, Kim N.; Sparks, Richard; George, Noble; Hawley, Sara M.; Wu, Wenting; Jensen, Jessica D.; Fleshner, Neil E. Share Save
Share Save
Share Save
Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study Saad, Fred; Hussain, Maha H. A.; Tombal, Bertrand; Fizazi, Karim; Sternberg, Cora N.; Crawford, E. David; Nordquist, Luke T.; Bogmann, Martin; Tutrone, Ronald; Shore, Neal D.; Belkoff, Laurence; Fralich, Todd; Jhaveri, Jay; Srinivasan, Shankar; Li, Rui; Verholen, Frank; Kuss, Iris; Smith, Matthew R. Share Save
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing Lenz, Lauren; Clegg, Wyatt; Iliev, Diana; Kasten, Chelsea R.; Korman, Howard; Morgan, Todd M.; Hafron, Jason; DeHaan, Alexander; Olsson, Carl; Tutrone Jr, Ronald F.; Richardson, Timothy; Cline, Kevin; Yonover, Paul M.; Jasper, Jeff; Cohen, Todd; Finch, Robert; Slavin Jr, Thomas P.; Gutin, Alexander Share Save
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study Tutrone, Ronald; Saad, Fred; George, Daniel J.; Tombal, Bertrand; Bailen, James L.; Cookson, Michael S.; Saltzstein, Daniel R.; Hanson, Sarah; Brown, Bruce; Lu, Sophia; Fallick, Mark; Shore, Neal D. Share Save
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer Freedland, Stephen J.; Luz, Murilo de Almeida; De Giorgi, Ugo; Gleave, Martin; Gotto, Geoffrey T.; Pieczonka, Christopher M.; Haas, Gabriel P.; Kim, Choung-Soo; Ramirez-Backhaus, Miguel; Rannikko, Antti; Tarazi, Jamal; Sridharan, Swetha; Sugg, Jennifer; Tang, Yiyun; Tutrone, Ronald F.; Venugopal, Balaji; Villers, Arnauld; Woo, Henry H.; Zohren, Fabian; Shore, Neal D. Share Save
Enzalutamide (enza) monotherapy for the treatment (tx) of prostate cancer with high-risk biochemical recurrence (BCR): EMBARK secondary endpoints De Giorgi, U. F. F.; Freedland, S. J.; Gleave, M. E.; Tutrone, R.; Bailen, J. L.; Roos, E.; Kliment, J.; Marx, G. M.; Karsh, L. I.; Ramirez-Backhaus, M.; Uchio, E.; Supiot, S.; Tang, Y.; Rosbrook, B.; Haas, G. P.; Rosales, M.; Zohren, F.; Shore, N. D. Share Save
Prostate-specific antigen (PSA) outcomes with darolutamide (DARO): Androgen-deprivation therapy (ADT) and docetaxel (DOC) in patients (pts) with high- and low-volume metastatic hormone-sensitive prostate cancer (mHSPC) in ARASENS Saad, F.; Hussain, M.; Tombal, B.; Fizazi, K.; Sternberg, C. N.; Crawford, E. D.; Boegemann, M.; Tutrone, R.; Littleton, N.; Srinivasan, S.; Verholen, F.; Kuss, I.; Smith, M. R. Share Save
Health-related quality of life (HRQoL) in nonmetastatic hormone-sensitive prostate cancer (nmHSPC) patients (pts) with high-risk biochemical recurrence (BCR) from the EMBARK study Freedland, S. J.; Gleave, M. E.; De Giorgi, U. F. F.; Rannikko, A.; Pieczonka, C.; Tutrone, R.; Venugopal, B.; Woo, H.; Backhaus, M. Ramirez; Supiot, S.; Lantz, A.; Ganguli, A.; Ivanova, J.; Kral, P.; Huang, S-P.; Saad, F.; Shore, N. D. Share Save
Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer Shore, Neal D.; Mehlhaff, Bryan A.; Cookson, Michael S.; Saltzstein, Daniel R.; Tutrone, Ronald; Brown, Bruce; Lu, Sophia; Fallick, Mark; Hanson, Sarah; Saad, Fred Share Save
ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis (May, 10.1038/s41391-023-00675-1, 2023) Tutrone, Ronald; Lowentritt, Ben; Neuman, Brian; Donovan, Michael J.; Hallmark, Elliot; Cole, T. Jeffrey; Yao, Yiyuan; Biesecker, Claire; Kumar, Sonia; Verma, Vinita; Sant, Grannum R.; Alter, Jason; Skog, Johan Share Save
ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis Tutrone, Ronald; Lowentritt, Ben; Neuman, Brian; Donovan, Michael J. J.; Hallmark, Elliot; Cole, T. Jeffrey; Yao, Yiyuan; Biesecker, Claire; Kumar, Sonia; Verma, Vinita; Sant, Grannum R. R.; Alter, Jason; Skog, Johan Share Save
A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer De La Cerda, Jose; Dunshee, Curtis; Gervasi, Lawrence; Sieber, Paul; Belkoff, Laurence; Tutrone, Ronald; Lu, Sophia; Gatoulis, Sergio C.; Brown, Bruce; Migoya, Elizabeth; Shore, Neal Share Save
Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy Kretschmer, Alexander; Kajau, Holger; Margolis, Eric; Tutrone, Ronald; Grimm, Tobias; Trottmann, Matthias; Stief, Christian; Stoll, Georg; Fischer, Christian A.; Flinspach, Claudia; Albrecht, Anja; Meyer, Lisa; Priewasser, Tina; Enderle, Daniel; Mueller, Romy; Torkler, Phillipp; Alter, Jason; Skog, Johan; Noerholm, Mikkel Share Save
Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies Margolis, Erik; Brown, Gordon; Partin, Alan; Carter, Ballentine; McKiernan, James; Tutrone, Ronald; Torkler, Phillipp; Fischer, Christian; Tadigotla, Vasisht; Noerholm, Mikkel; Donovan, Michael J.; Skog, Johan Share Save
Efficacy and safety of relugolix vs leuprolide (LEU) in men with advanced prostate cancer (APC): Clinical subgroup analysis from the phase III HERO study Saltzstein, D. R.; Shore, N. D.; Saad, F.; George, D. J.; Cookson, M. S.; Tutrone, R.; Akaza, H.; Bossi, A.; Brown, B.; Selby, B.; Lu, S.; Walling, J.; Tombal, B. Share Save
Geographical assessment of efficacy and safety of relugolix: A subgroup analysis from the randomized, phase III HERO study vs leuprolide (LEU) in men with advanced prostate cancer (APC) Bossi, A.; Shore, N. D.; Tutrone, R.; Cookson, M. S.; George, D. J.; Saltzstein, D. R.; Akaza, H.; Brown, B.; Selby, B.; Lu, S.; Walling, J.; Tombal, B.; Saad, F. Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
EUROPEAN UROLOGY.png)
OAAI
.png){kind=icon}
Share.png){kind=icon}
Save